IGF-2-mediated Akt phosphorylation was also strongly blocked by GSK1838705A, ceritinib and linsitinib suggesting that the mechanism by which these drugs inhibit meningioma cell growth is mainly via IGF1R blockade. Here, AKT1 is linked to meningioma.